Likelihood of Return for Screening Low After False-Positive Mammogram
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Sept. 4, 2024 -- Women are less likely to return for subsequent screening after false-positive mammography results, according to a study published online Sept. 3 in the Annals of Internal Medicine.
Diana L. Miglioretti, Ph.D., from the University of California in Davis, and colleagues examined the association between screening mammography results and the probability of subsequent screening in a cohort study involving 3,529,825 screening mammograms (3,184,482 true negatives and 345,343 false positives) performed from 2005 to 2017 among 1,053,672 women aged 40 to 73 years.
The researchers found that the likelihood of returning was higher after a true-negative result than after a false-positive recall for additional imaging only, short-interval follow-up, or biopsy (adjusted absolute difference, −1.9, −15.9, and −10.0 percentage points, respectively). The largest decreases in the probability of returning after a false positive versus a true negative were seen for Asian and Hispanic/Latino women for short-interval follow-up or biopsy (−20 to −25 points and −13 to −14 points, respectively). A false-positive result on the second of two screening mammograms within five years was associated with a reduced probability of returning for a third, irrespective of the first screening result.
"Physicians should educate their patients about the importance of continued screening after false-positive results, especially given the associated increased future risk for breast cancer," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Odds of Advanced Cancer, Breast Cancer Death Lower in Screen-Detected Disease
THURSDAY, June 5, 2025 -- For patients aged 40 years or older, screen-detected breast cancer is associated with lower odds of advanced cancer, mastectomy, and breast...
Nodal Irradiation Does Not Reduce Recurrence, Death for ypN0 Breast Cancer
THURSDAY, June 5, 2025 -- For patients with node-positive breast cancer who become pathologically tumor-free with negative axillary nodes (ypN0) after neoadjuvant chemotherapy...
ASCO: Vepdegestrant Ups Survival in ER+, HER2− Advanced Breast Cancer With ESR1 Mutations
MONDAY, June 2, 2025 -- For patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer, the oral...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.